Actively Recruiting
Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA ")
Led by Imagine Institute · Updated on 2023-08-21
200
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Recurrent respiratory papillomatosis (RRP) is a rare disease. However, it is the most common benign laryngeal tumor in children. To date, no epidemiological data are available in France. The aim of this study is to establish the epidemiology of juvenile PPR.
CONDITIONS
Official Title
Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA ")
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with juvenile PRR (disease onset before age 18)
- Followed in the MALO CRMR
- Followed in one of the MALO network's CCMRs
- Followed in one of the main correspondent centers
You will not qualify if you...
- Patients objecting to the collection of their personal data
- Parents of minor patients objecting to the collection of their child's personal data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
hôpital Necker Enfants malades
Paris, France, 75015
Actively Recruiting
Research Team
N
Nicolas LEBOULANGER, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here